Related Experiment Video
Updated: Sep 23, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
889
COVID-19 and Kidney Disease: A Clinical Perspective
Panagiotis Theofilis1, Aikaterini Vordoni1, Rigas G Kalaitzidis1
1Department of Nephrology, General Hospital of Nikaia-Piraeus "Agios Panteleimon", Piraeus, Nikaia 18454, Greece.
Current Vascular Pharmacology
|May 16, 2022
Summary
COVID-19 significantly impacts kidney health, causing acute kidney injury (AKI) and worsening outcomes for those with chronic kidney disease. Early detection and careful management are crucial, especially for kidney transplant recipients.
Area of Science:
- Nephrology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease-19 (COVID-19) pandemic presents significant global health challenges.
- Chronic kidney disease (CKD) is a critical risk factor for severe COVID-19 outcomes.
- Acute kidney injury (AKI) is a prevalent complication of COVID-19, indicating poor prognosis.
Purpose of the Study:
- To review the pathophysiology and clinical implications of AKI in COVID-19 patients.
- To discuss early detection markers and management strategies for COVID-19 associated AKI.
- To highlight the specific risks and management considerations for kidney transplant recipients with COVID-19.
Main Methods:
- Literature review and synthesis of current research on COVID-19 and kidney injury.
- Analysis of pathophysiological mechanisms including inflammation, endothelial dysfunction, and viral insult.
- Examination of prognostic indicators, biomarkers, and renal replacement therapy (RRT) in COVID-19 AKI.
Main Results:
- AKI in COVID-19 is multifactorial, linked to inflammation, sepsis, and potential direct viral effects.
- Early detection markers include inflammatory biomarkers and urinary SARS-CoV-2 load.
- Recovery from COVID-19 AKI is variable; pre-existing CKD and high creatinine predict progression.
Conclusions:
- COVID-19 AKI requires careful management, with potential long-term consequences like dialysis dependence.
- Kidney transplant recipients face heightened risks of severe COVID-19, mortality, AKI, and graft rejection.
- Preventive strategies and tailored management are essential for vulnerable kidney patients during the pandemic.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
116
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
116
01:25Chronic Kidney Disease I: Introduction
85
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
85
01:28Chronic Kidney Disease III: Interprofessional Care
90
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
90
01:29Acute Kidney Injury III: Clinical Manifestations
114
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
114
01:29Acute Kidney Injury II: Pathophysiology
109
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
109
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
66
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
66